Background Acute myocardial ischemia is accompanied by an increase in glucose uptake and metabolism, which appears to be important in protecting myocardial cells from irreversible ischemic injury. Because insulin augments myocardial glucose uptake by inducing the translocation of glucose transporters from an intracellular compartment to the plasma membrane, we hypothesized that acute ischemia would trigger a similar translocation.
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Methods and Results We used a subcellular fractionation method to separate intracellular membranes and plasma membranes from control, ischemic, and hypoxic Langendorff-isolated perfused rat hearts and determined the expression of the major myocardial glucose transporter, GLUT4, in these separated membrane fractions. We found that translocation of GLUT4 molecules occurred in ischemic, hypoxic, and insulintreated hearts and in hearts that underwent ischemia plus insulin treatment. The percentages of GLUT4 molecules I schemia induces multiple changes in myocardial cell metabolism. Prominent among these changes is a marked increase in glucose uptake and use that occurs shortly after the onset of mild to moderate ischemia.1 Multiple clinical and experimental trials have shown that increased glucose uptake and metabolism during acute myocardial ischemia are associated with preserved diastolic and systolic myocardial function, decreased release of myocardial enzymes, improved recovery during reperfusion, and prevention of ischemic contracture.1-6 However, the mechanism by which ischemia stimulates glucose uptake remains unknown.
Over the past several years, cDNAs have been isolated for the proteins that transport glucose into myocardial cells.7-18 The predominant transporter in cardiac muscle is the insulin-responsive glucose transporter GLUT4 . 19 It appears that very few GLUT4 molecules are located on the plasma membrane of myocardial cells under basal conditions. However, when exposed to maximal insulin levels, approximately 40% of the myocardial GLUT4 molecules are translocated to the plasma membrane. 20 This increase in plasma membrane GLUT4 molecules appears to be the major mechanism by which insulin acutely stimulates glucose uptake in present on the plasma membrane in the different conditions were as follows: control. 18 beating at the end of the experimental period were used for further assessment. At the end of the experimental period, the hearts were drained of excess perfusate and snap-frozen in liquid nitrogen.
Subcellular Membrane Fractionation
Membrane fractionation was performed by use of a modification of the method of Zaninetti et al. 23 For the initial experiments, three hearts exposed to a single condition (control, ischemia, or hypoxia) were combined together. For subsequent experiments, the protocol was performed with individual hearts (other details of the fractionation protocol were identical). The hearts were thawed on ice, and each heart was trimmed of fat and washed in cold phosphate-buffered saline, pH 7.4. The heart was then transferred to an ice-cold Petri dish containing 4 mL of 10 mmol/L sodium bicarbonate and 5 mmol/L sodium azide, pH 7.0, and immediately minced with a razor blade. The resultant slurry was then homogenized with a Brinkmann Polytron tissue homogenizer at setting 5 for 20 seconds. The homogenate was transferred to a handheld 7-mL glass/glass homogenizer and subjected to 10 pestle strokes. A 100-mL aliquot of the homogenate was removed for later analysis (crude homogenate); the remainder was centrifuged at 7000g for 20 minutes. The resultant supernatant was reserved for preparing the microsomal membrane (MM) fraction, containing intracellular membranes, and the pellet was used for preparing the plasma membrane (PM) fraction. The pellet was resuspended in 4 mL of 10 mmol/L Tris-HCl, pH 7.4, and centrifuged at 200g for 20 minutes. The pellet was discarded, and supernatant was evenly divided into 0.8-mL portions, each of which was gently layered on top of a 20% (vol/vol) Percoll gradient in buffer C (255 mmol/L sucrose; 10 mmol/L Tris-HCl, pH 7.4; 2 mmol/L EDTA) in a 4-mL tube and centrifuged at 55 00g for 1 hour. The band at density 1.030 as determined by density marker beads (Pharmacia) was aspirated and pelleted by centrifugation at 170 000g for 1 hour and resuspended in 0.2 mL of buffer C as the PM fraction. The supernatant from the original 7000g centrifugation was centrifuged at 48 000g for 20 minutes. The membranes in the resultant supernatant were then pelleted by centrifugation at 170 OOOg for 1 hour and resuspended in 0.2 mL of buffer C as the MM fraction. Protein concentrations for each fraction were determined by Coomassie protein assay (Pierce).
Relative enrichments of the crude homogenates and PM and MM fractions were determined by analysis of marker enzymes. NADPH-cytochrome c reductase is a mitochondrial enzyme that is enriched in the microsomal fraction,23 and Na+,K+-ATPase al and a2 subunits are enriched in the PM fraction. NADPH-cytochrome c reductase activity was determined by a modification of the protocol of Williams and Kamin.24,25 Relative levels of Na+ ,K+-ATPase al or a2 subunit were determined by immunoblotting using rabbit anti-rat polyclonal antisera specific for each isotype (UBI). Antibodies to either subunit gave identical results in initial experiments. However, blots with the al antibody were more intensely labeled, so this antiserum was used exclusively in later experiments.
Immunoblot Analysis GLUT4 levels were semiquantified by immunoblotting. Aliquots of 50 jig of the MM and PM fractions and crude homogenate from either fasted and insulin-treated hearts or control, ischemia, hypoxia, and insulin plus ischemia hearts were electrophoresed on individual 10% SDS-polyacrylamide gels. Immunoblotting and GLUT4 determinations were performed as previously described.26 The contents of the gels were transferred electrophoretically to nitrocellulose membranes, which were then stained briefly with Ponceau S to determine uniformity of electrophoretic transfer. The membranes were washed in Tris-buffered saline (TBS) (20 mmol/L Tris-HCl, pH 7.5; 150 mmol/L NaCl; 1% Nonidet-P-40 [Sigma] ) and blocked in 5% dry milk in TBS. The membranes were then incubated with a 1:800 dilution of a rabbit polyclonal antiserum directed against a peptide encoding the 16 carboxy-terminal amino acids of rat GLUT426 (gift of Dr Maureen Charron). The filters were then washed three times in TBS, blocked again, and incubated with '251-donkey antirabbit IgG (ICN). Finally, the filters were washed three times in TBS, dried, and exposed to film. Semiquantification of the 1251 signal was determined either by direct scintillation counting of the excised GLUT4 membrane bands or by videodensitometry using the National Institutes of Health IMAGE 1.43 program. For densitometric analysis, several exposures of each blot were performed on preflashed Xomat-AR film, and only those films were used for which the resultant autoradiographic signals were within the linear response range of the film.
Data Analysis GLUT4 data were expressed as the relative number of GLUT4 molecules in 50 mg protein from the various fractions from paired sets of control, ischemia, and hypoxia hearts. For all groups, the data were also expressed as the percentage of total GLUT4 protein in either of the two membrane fractions as follows:
where OD is the relative densitometric value of GLUT4 in 50 mg of membranes and % of total protein recovery in MM (or PM) fraction is the amount of protein recovered in final PM or MM fraction divided by the amount of protein in the original crude homogenate. Expression of the GLUT4 data in this way allows comparison with immunohistochemical findings from other studies in which GLUT4 translocation has been analyzed. 20 The equations also correct for variabilities in the percentage of total cardiac protein recovered in each fraction. Statistical analysis of GLUT4 translocation was performed by ANOVA, and differences between groups were determined by the Fisher least significant difference test. Differences were considered significant at 95% confidence intervals.
Results
MM fractions derived from the subcellular fractionation method were substantially enriched in NADPHcytochrome c reductase activity, and the PM fractions were substantially enriched in the a subunits of the Na+,K+-ATPase (Table) . None of the experimental treatments changed the relative enrichments of the marker enzymes in either of the fractions. Along with substantial marker enrichment, the fractionation protocol resulted in a recovery of approximately 60% of the total GLUT4 molecules in the MM and PM fractions (Table) . Total GLUT4 recovery was not affected by the various experimental conditions.
Compared with control animals, maximal insulin stimulation produced a 1.9-fold increase in the number of GLUT4 molecules detected in the myocardial PM fraction and a 62% decrease in the number of MM GLUT4 molecules. When these data were corrected for variations in protein recovery and expressed as the percentage of total GLUT4 molecules found in the PM fraction, insulin increased PM GLUT4 expression from 18+2.8% to 61.1±2.6%, indicating translocation of Both of these studies were performed before the molecular cloning of GLUT4 and its identification as the major myocardial glucose transporter. Therefore, in Wheeler's study, the degree of translocation was evaluated by comparing three properties of the plasma and microsomal membrane fractions: reconstituted glucose transport activity; binding of the ligand cytochalasin B, which recognizes all glucose transporter isoforms to some extent; and immunoblotting with an antibody that recognizes GLUT1, a transporter that is expressed only at low levels in myocardium. '9 In both studies, insulin caused a 60% to 100% increase in PM glucose transporters and a 16% to 38% decrease in MM fractions (called "high-speed pellet" fractions).28 '29 Hypoxia caused similar changes and induced a 20% to 70% increase in PM glucose transporters and a 20% to 30% decrease in glucose transporters in the microsomal fraction.29 Using the same membrane fractionation procedure, Rattigan et a130 documented GLUT4 translocation after catecholamine stimulation, with a 7% increase in GLUT4 molecules in the fractions enriched in plasma membranes, and a 34% to 38% decrease in GLUT4 molecules in the fraction enriched in microsomal membranes. Zaninetti et a123 used a much different fractionation method yielding PM protein recoveries approximately 5 times greater than those from the Watanabe and Wheeler protocols. Using cytochalasin B binding determinations, they also documented a twofold increase in PM glucose transporters with insulin.23 More recently, Slot et a120 studied the extent of GLUT4 translocation in rat hearts induced by a combination of maximal insulin and exercise stimulation using immunohistochemical localization of GLUT4. In contrast to results found with subcellular fractionation, these investigators demonstrated minimal (<1%) PM expression of GLUT4 under basal, fasting conditions and showed that insulin plus exercise induced translocation of approximately 42% of the GLUT4 molecules to the PM. By thus demonstrating a much greater degree of glucose transporter translocation than shown by the other studies, these findings called into question the ability of subcellular fractionation techniques to adequately separate plasma membranes from other intracellular membranes.
With minor modifications of the membrane fractionation protocol of Zaninetti et al, we found that approximately 18% of GLUT4 molecules were expressed in the PM fraction in fasted animals and that insulin caused translocation of another 43% of the total GLUT4 molecules. The differences between our results and those of the earlier fractionation studies are most likely a result of our use of a different fractionation procedure that allowed us to capture approximately 60% of GLUT4 molecules within our final two fractions and produced relatively small amounts of cross-contamination. Our results, however, also differ to some extent from those of Zaninetti et al. 23 These differences may be a result of our use of semiquantitative immunoblotting with a specific GLUT4 antibody rather than the more difficult and less specific cytochalasin B binding assays.
Another potential factor is that the cytochalasin B binding experiments in the previous studies would have detected GLUT1 molecules as well as GLUT4. However, GLUT1 appears to be expressed at much lower levels than GLUT4 in rat myocardium.19 Therefore, this difference in technique is unlikely to have contributed significantly to the higher basal PM GLUT expression and diminished translocation found in the earlier studies. Of all the fractionation studies, our results are most consistent with the immunolocalization findings of Slot et al. 20 The higher PM GLUT4 expression found under basal conditions in our study is most likely a result of contamination of the PM fraction with intracellular membranes, as evidenced by enrichment of a mitochondrial enzyme, NADPH-cytochrome c reductase, in the PM fraction. The relative contamination was not substantial, however, and although both basal and insulinstimulated PM GLUT4 expression were somewhat overrepresented with this method, the absolute degree of translocation was nearly identical to that detected by the immunolocalization study. Therefore, myocardial membrane fractionation accompanied by specific immunoblotting appears to produce reliable data on subcellular glucose transporter localization and can be used as a complement to immunohistochemical studies for this purpose. Furthermore, this method possesses several distinct advantages over immunohistochemical studies.
For example, quantification of specific proteins is easier and more reproducible, and multiple samples can be more reliably assayed and compared.
Our data suggest that much of the increase in glucose metabolism of acutely ischemic myocardial cells is caused by the translocation of GLUT4 molecules. An increase in plasma membrane transporters leads to more rapid glucose uptake, and because myocardial glucose uptake and phosphorylation normally appear to be rate limiting for glucose metabolism,32-35 the number of transporters on the cell surface at least partly determines the rate of myocardial glucose metabolism. Indeed, conditions or stimuli that acutely augment glucose uptake and metabolism in skeletal muscle and in other tissues do so through the translocation of glucose transporters. 27 It is interesting that global ischemia stimulates GLUT4 translocation less than does maximal insulin treatment. Ischemia alone increased PM GLUT4 molecules from 18% to 41%, whereas insulin treatment alone and ischemia plus insulin treatment resulted in the plasma membrane expression of 61% and 67% of total myocardial GLUT4 molecules, respectively. We studied the effects of ischemia on the translocation of the GLUT4 isoform only, and it is possible that myocardial ischemia also causes translocation of the other cardiac transporter, GLUT1, to the plasma membrane. Under acute conditions, such as those of the present study, GLUT1 translocation is unlikely to contribute substantially to myocardial glucose uptake, because GLUT1 appears to be expressed at much lower levels than GLUT4 in heart.19 However, under more chronic ischemic or hypoxic conditions, GLUT1 expression could be induced to physiologically significant levels. Indeed, it was shown recently that chronic hypobaric hypoxia resulted in a modest increase in GLUT1, but not GLUT4, mRNA and protein expression in rat hearts.42 Interestingly, GLUT4 expression actually decreased in the right ventricle of hypobaric hypoxic rats.42 Thus, many alterations in glucose transporter expression may accompany chronic hypoxic and ischemic conditions. It would be intriguing to determine the exact role that glucose transporter expression plays in mediating myocardial glucose metabolism under these chronic conditions and to determine whether modulating this response alters myocardial viability. Molecular reagents and techniques with which these important issues may be addressed are now available.
